<DOC>
	<DOCNO>NCT02550847</DOCNO>
	<brief_summary>The aim study evaluate MR/PET functional molecular imaging prediction prognosis patient suspect pancreatic cancer .</brief_summary>
	<brief_title>Evaluation Prognosis With Integrated MRI/PET Patients With Pancreatic Cancer</brief_title>
	<detailed_description>The result MR/PET compare prospectively dedicate MDCT MR imaging , pathologic result , clinical outcome ass value MR/PET pancreatic cancer .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>1 . Diagnosed pancreatic cancer 2 . Between 20~90 year old 3 . ECOG 02 4 . Normal renal function 5 . Measurable tumor size ( &gt; 1cm ) 1 . Contraindication MRI exam 2 . Claustrophobia 3 . Renal insufficiency 4 . Other malignancy 5 . Pregnancy lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>MR/PET</keyword>
	<keyword>pancreatic cancer</keyword>
</DOC>